Search events

Search by
Events by year

2016 Life Sciences Symposium (attorney session)

Luncheon Panel: Prescription Drug Prices

May 23, 2016
12:00–1:45 pm

The shifting sands of competition and innovation are evident across the industry—innovators, generics, small molecule and biologics—and drug prices are, once again, front line news and a target for policy makers and litigation.

Our panel will bring together top minds from the legal, regulatory, and commercial communities to shed light on:

  • How economic forces can drive prices for branded and generic drugs 
  • How government agencies, such as the FDA and CMS, can wield their policy making abilities to influence drug markets and prices 
  • How litigation will be used in addressing drug prices 
  • What the future holds for both legislative and regulatory initiatives aimed at drug pricing

Panelists include:

  • Tamer Abdelgawad, MA—Senior Director of International Policy, Pfizer 
  • Jim Cohen, JD—Former FDA senior legal advisor
  • Allan Coukell, BScPharm—Senior Director of Health Programs, Pew Charitable Trusts
  • Jim Stansel, JD—Partner, Sidley Austin 
  • Anne Wilson, MBA—Head of North America Policy, Mylan 
  • Chris Stomberg, PhD—Partner, Bates White (moderator)

Willard InterContinental (Crystal Room) 
1401 Pennsylvania Avenue, NW 
Washington, DC 20004 

11:30–12:00 p.m.

Panel and lunch
12:00–1:45 p.m.

Registration is complimentary. If you are interested in attending, please email Ngar Eldredge.